Endocrine Disorders Induced by PD-1/PD-L1 Inhibitor and Related Treatment
Immune checkpoint therapy is a new mode of tumor therapy. At present, many kinds of PD-1/PD-L1 inhibitors have been approved for clinical application on various tumors, such as malignant melanoma, lung cancer, bladder cancer, lymphoma, etc. However, with the gradual promotion and application in clin...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | ZH |
| Publié: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d8ae6841853849339273588500c2bc99 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|